期刊文献+

类风湿关节炎患者血清肿瘤标志物检测的临床意义 被引量:4

The Clinical Significance of the Tumor Marker Detection in Patients with Rheumatoid Arthritis
下载PDF
导出
摘要 目的:观察类风湿关节炎患者血清肿瘤标志物的含量变化及其阳性率,分析肿瘤标志物与RA疾病活动度的关系及肿瘤发生情况。方法:选择2005年1月~2011年12月确诊为类风湿关节炎同时行肿瘤标志物检测的60例住院患者作为RA组,以年龄性别相匹配的健康体检者56例作为对照组。收集类风湿关节炎的疾病活动分数(DAS28)、血沉(ESR)、C-反应蛋白(CRP)、类风湿因子(RF)等资料;肿瘤标志物升高患者均进行胸片、胸部高分辨CT、盆腹部超声或CT、胃镜、肠镜等相关检查明确肿瘤情况,并随访2年以上观察后续肿瘤发生情况。结果:与对照组相比,RA组除CA153外,血清CEA、CA125、CA199数值水平及阳性率均偏高,差异有统计学意义,P〈0.05;但RA组肿瘤标志物升高与疾病活动分数、血沉或C-反应蛋白无相关性,肿瘤标志物升高的患者未发现肿瘤共存依据。结论:类风湿关节炎患者血清CEA、CA125、CA199升高,但并不提示相关肿瘤共存,以后患肿瘤风险是否增加仍需继续随访。 Objective: To observe the change and the positive rate of serum tumor markers in patients with rheumatoid arthritis, and analyze the relationship between tumor markers and RA disease activity and tumor occurrence. Method: From January 2007 to December 2013, 60 hospitalized patients with rheumatoid arthritis and tumor markers were detected were selected as RA group, and 56 healthy individuals with age and sex matched were selected as the control group. Collected rheumatoid arthritis disease activity score (DAS28), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and rheumatoid factor (RF) data; the tumor situation of the patients with tumor markers elevation should be confirmed by chest X-ray, chest high resolution CT, pelvic and abdominal ultrasound or CT, endoscopy, and colonoscopy examination, and they were followed up for more than 2 years to observe the subsequent tumor occurrence. Results: Compared with the control group,'the serum levels and the positive rates of CEA, CA125 and CA199 of the RA group were higher, except the CA153, and the difference was statistically significant, P〈0.05; but the tumor sign elevation of the RA group was not correlated with the disease activity score, erythrocyte sedimentation rate and C-reactiVe protein, the tumor coexisting basis were not found in the patients with tumor marker elevation. Conclusion: Serum CA125, CEA and CA199 were elevated in patients with rheumatoid arthritis, but it does not suggest that the tumor is associated with the development of the tumor. If the risk of cancer will increase need continuing follow up.
出处 《实用中西医结合临床》 2015年第8期5-7,共3页 Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine
关键词 类风湿关节炎 肿瘤标志物 临床意义 Rheumatoid arthritis Tumor markers Clinical significance
  • 相关文献

参考文献12

  • 1Boussios S,Pentheroudakis G,Somarakis G,et al.Cancer diagnosis in a cohort of patients with Sjogren’s syndrome and rheumatoid arthritis:a single-center experience and review of the literature[J].Anticancer Res,2014,34(11):6669-6676.
  • 2Szekanecz E,Sándor Z,Antal-Szalmás P,et al.Increased production of the soluble tumor-associated antigens CA19-9,CA125,and CA15-3 in rheumatoid arthritis:potential adhesion molecules in synovial inflammation[J]?Ann N Y Acad Sci,2007,1108:359-371.
  • 3Ehrenfeld M,Shoenfeld Y.Malignancies and autoimmune rheumatic disease[J].J Clin Rheumatol,2001,7(1):47-50.
  • 4Lazarus MN,Robinson D,Mak V,et al.Incidence of cancer in a cohort of patients with primary Sjogren’s syndrome[J].Rheumatology(Oxford),2006,45(8):1012-1015.
  • 5董振南,董静肖,田亚平.癌胚抗原升高在良恶性疾病中的辅助诊断价值[J].标记免疫分析与临床,2011,18(1):1-4. 被引量:21
  • 6Tsavaris N,Mavragani CP,Pikazis D.Rheumatoid arthritis:correlation between rheumatoid factor levels and CA-125 tumour marker elevation[J].Ann Rheum Dis,2007,66(7):980.
  • 7Bergamaschi S,Morato E,Bazzo M,et al.Tumor markers are elevated in patients with rheumatoid arthritis and do not indicate presence of cancer[J].Int J Rheum Dis,2012,15(2):179-182.
  • 8曾克勤,陈志伟,强红伟,武剑.结缔组织病相关肺间质病变患者血清肿瘤标志物的表达特点[J].中国血液流变学杂志,2012,22(4):604-606. 被引量:7
  • 9夏俊波,严秀娟,任振义,陈灏,王娇莉.肿瘤标志物在类风湿性关节炎伴间质性肺病中的临床意义[J].浙江医学,2012,34(12):984-985. 被引量:5
  • 10胡盈莹,胡望平,黄兢姚,冯福英,王海林,汪升,章宏斌,周长邵.癌抗原在胸腹腔积液及相关疾病诊断与治疗中的应用[J].实用诊断与治疗杂志,2007,21(3):168-170. 被引量:7

二级参考文献43

  • 1胡盈莹,胡望平,黄兢姚,冯福英,王海林,汪升,章宏斌,周长邵.癌抗原在胸腹腔积液及相关疾病诊断与治疗中的应用[J].实用诊断与治疗杂志,2007,21(3):168-170. 被引量:7
  • 2孙水根,黄继华.血清CA125浓度改变对慢性心力衰竭患者临床诊治的价值[J].中华急诊医学杂志,2007,16(4):424-426. 被引量:27
  • 3Thompson J A.Molecular cloning and expression of carcinoembryonic antigen gene family members[J].Tumor Biol,1995,16:10-16.
  • 4Lamerz R.Role of tumor markers cytogenetics[J].Ann Oncol,1999,10 (Suppl 4):145-149.
  • 5安德子 陈亚莉 何丹 等.296例胃肠道活检组织CEA含量与病理结果分析.中华核医学杂志,1996,2:137-137.
  • 6Duman D, Palit F, Simsek E, et al.Serum carbohydrate antigen 125 levels in advanced heart failure: relation to B-type natriuretic peptide and left atrial volume[J].Eur J Heart Fail,2008,10(6):556-559.
  • 7Bonfrer J M, Norse C M, Verstraeten R A, et al. Clinical evaluation of the Byk LIA-mat CA125 II assay: discussion of a reference value[J]. Clin Chem,1997, 43(3) : 491-497.
  • 8Robertson D M, Cahir N, Burger H G, et al. Combined inhibin and CA125 assays in the detection of ovarian eaneer [J]. Clin Chem, 1999, 45(5): 651-658.
  • 9Sturgeon C. Practice Guidelines for Tumor Marker Use in the Clinic[J]. Clin Chem,2002, 48(8):1151-1159.
  • 10Davelaar E M, Schutter E M, yon Mensdorff Pouilly S. et al. Clinical and technical evaluation of the ACS: OV serum assay and comparison with three other CA125-detecting assays [J]. Ann Clin Biochem, 2003, 40( 6): 663-673.

共引文献37

同被引文献18

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部